Assessment of quality assurance capability for medicines in community pharmacies in two cities in Nigeria
Main Article Content
Abstract
Background: Medicine quality is a global concern and lack of reliable quality assurance (QA) system for medicines may be contributory to the high level of spurious medicines in many developing countries. Objectives: The study evaluated the level of institutionalization of QA components for medicine inventory in community pharmacies in two cities of Osun State in Nigeria as a measure of QA capability and explored for factors influencing QA capability.
Methods: A set of pretested semi-structured questionnaire was administered to community pharmacists practicing in Oshogbo and Ile-Ife. The instrument sought information on the level of institutionalization of essential components of QA, and explored for factors influencing QA, both on ordinal scales with weighting scores of 1-5 and 0-4 respectively. Descriptive statistics were used to summarize the data. Chi square, Spearman's rank correlation as well as multiple and ordinal regressions were used to evaluate the respondents' opinions at 5% level of significance.
Results: Only two (12.5%) of the essential components of QA had been implemented (WA≈ 4) and none institutionalised (WA≈5). The three most prominent factors influencing QA capability were management commitment, suppliers and government regulatory control all with median score of 4.
Conclusion: Quality assurance capability for medicine inventory in the community pharmacies was low.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
Share
References
Schommer JC, Pedersen CA, Doucette WR, Gaither CA, Mott DA (2002). Community Pharmacists' Work Activities in the United States
during 2000. Journal of the American Pharmacists Association 42(3): 399-406.
Ziance, RJ (2008). Roles for pharmacy in combating counterfeit drugs. JAPHA 48(4): e71-e91.
Gautam CS, Utreja A, Singal GL (2009). Spurious and counterfeit drugs: a growing industry in the developing world. Postgraduate Medical Journal 85:251-256.
Bah-Traore N (2012). Quality Assurance and Safety issue of Pharmaceutical Products marketed in Developing countries. Published
Ph.D. Thesis on the internet, Available at: http://hss.ulb.uni-bonn.de/2012/3056/3056.pdf. Accessed January 25, 2013.
Erhun WO (2012). Poverty, Disease and Drugs in Regional Development. West African Journal of Pharmacy 23 (2) 3 -13.
FIP. (1997). Standards for quality of Pharmacy Services – Good Pharmacy Practice. Available at:http://www.fip.org/good_pharmacy_practice.
Accessed May 7, 2014.
Amin AA Kokwaro GO (2007). Antimalarial drug quality in Africa. Journal of Clinical Pharmacy and Therapeutics 32: 429–440.
World Health Organization (2011). WHO good distribution practices for pharmaceutical products: WHO Technical Report Series, No. 957.
Available at: http://www.who.int/medicinesAA. Accessed May 8, 2014.A Accessed May 8, 2014.
Federal Government of Nigeria (2012). National Drug Distribution Guidelines. Federal Ministry of Health. Second Edition. Abuja. Available at
http://nascp.gov.ng/demo/wp-content/uploads/2014/02/National-DrugDistribution-Guidelines.pdf. Accessed June 10, 2014.
Federal Government of Nigeria (2005). National Drug Policy. 1 Revision. Abuja: Federal Ministry of Health Publications. Available at:
http://collections.infocollections.org/whocountry/en/d/Js6865e/. Accessed February 3, 2015.
World Health Organization (1999). Quality Assurance of pharmaceuticals: A compendium of guidelines & related materials GMP & inspection. Geneva, 2:19-27. Available at: http://www.who.int/quality assurance/Quality Assurance Pharm. Accessed June 1, 2014.
Silimperi DR, Franco LM, Zanten TVV, Macaulay C (2002). A Framework for Institutionalizing Quality Assurance. International journal of healthcare quality assurance 14(1): 67–73.
Mannu T, Priyavrat T (2007). The Quality Brilliance through Brilliant People; Quality World 4(2): 1-10.
Defoe JA, Juran JM. Juran's Quality Handbook: The Complete Guide to Performance Excellence. New York: McGraw-Hill, 2010
Hackman JR, Wageman R (1995). Total Quality Management: Empirical, Conceptual, and Practical Issues. Administrative Science Quarterly
(2): 309-342
Caudron JM, Ford N, Henkens M, Macé, C, KiddleMonroe R, Pinel J (2008). Substandard medicines in resource-poor settings: a problem that can no longer be ignored. Tropical Medicine and International Health 13:1062-72.
Wertheimer AI, Santella TM (2005). Counterfeit drugs: defining the problem and finding solutions. Expert Opinion on Drug Safety 4(4):
-622.
Brown LD (1995). Lessons learned in institutionalization of quality assurance programs: an international perspective.
International Journal for Quality in Health Care 7: 419-425.
Rogers EM. Diffusion of Innovations. 5 Edn. Glencoe: Free Press, 1995. Available at: http://books.simonandschuster.com/Diffusionof-Innovations-5th-Edition/Everett-—Rogers/9780743222099. Accessed June 5, 2014.
Nwalieji AH, Ajayi AR (2009). Farmers' adoption of improved vegetable production practices under the National Fadama Phase One
Development Project in Anambra State of Nigeria. African Journal of Biotechnology 8(18): 4895-4406.
Law E and Youmans SL (2011). Combating Counterfeit Medications: The California Pharmacist Perspective. Journal of Pharmacy Practice 24(1): 114-121.
Ongoagchai S, Harun-Or-Rashid M, Sakamoto J (2011). Factors Affecting Drug Quality Problems in Thailand. Quality Assurance Journal 14: 9-17.
Storey J (2013). Factors affecting the adoption of quality assurance technologies in healthcare. Journal of Health Organisation and Management 27(4):498-519.
Yamane Y. Statistics: An introductory analysis. New York: Hamper, 1964
Hafter JL, Fedor VL (2004). Emergency Medical Services and the Law: EMS continuing education series. ISBN 0763720682, 9780763720681.
eBook: Jones & Bartlett Learning. Available at: https://books.google.com.ng/books?isbn=0763720682. Accessed May 8, 2014.
Black SA, Porter LJ (1996). Identification of the Critical Factors of TQM. Decision Sciences27(1):1-21.
Singh SB, Dhalla RS (2010). Effect of Total Quality Management on Performance of Indian Pharmaceutical Industries. Proceedings of the
International Conference on Industrial Engineering and Operations Management Dhaka, Bangladesh. Available at:
http://www.iieom.org/index-3.htm. Accessed July 18, 2014.